Abliva Reports Positive Interim Analysis Of KL1333 FALCON Study
18 Jul 2024 //
GLOBENEWSWIRE
Abliva To Host KOL Event On KL1333 In Primary Mitochondrial Disease
13 May 2024 //
GLOBENEWSWIRE
Owl, Abliva Partner on Traumatic Brain Injury Drug
20 Nov 2023 //
CONTRACT PHARMA
Owl Therapeutics Enters a Strategic Clinical Collaboration With Abliva
17 Nov 2023 //
PR NEWSWIRE